证券之星消息，港通医疗(301515)08月12日在投资者关系平台上答复投资者关心的问题。 投资者提问：请问到8.10股东人数是多少？ 港通医疗回复：尊敬的投资者，您好！公司截至2025年8月8日股东总户数为9469户，感谢您的关注。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Group 1 - The core point of the article highlights the financing activities of Kangtong Medical, which had a financing buy-in amount of 0.15 billion yuan on August 11, ranking 2087 in the market [1] - Over the last three trading days from August 7 to August 11, Kangtong Medical received financing buy-ins of 0.08 billion yuan, 0.17 billion yuan, and 0.15 billion yuan respectively [1] - On the same day, the company had a financing repayment amount of 0.11 billion yuan, resulting in a net buy of 4.1457 million yuan [1] Group 2 - In terms of securities lending, there were no shares sold or net sold on that day, indicating no activity in this area for Kangtong Medical [2]

Group 1 - The core point of the article highlights that Kangtong Medical (301515) has recently registered a new software copyright for the "Medical Gas Alarm System Software V1.0" project, marking a total of 11 new software copyrights registered this year, which is a 57.14% increase compared to the same period last year [1] - In 2024, the company invested 24.2452 million yuan in research and development, which represents a year-on-year decrease of 18.83% [1] - Kangtong Medical has made investments in 12 enterprises and participated in 2,973 bidding projects, indicating active engagement in the market [1] Group 2 - The company holds 31 trademark registrations, 310 patents, and 35 copyright registrations, showcasing a robust intellectual property portfolio [1] - Additionally, Kangtong Medical possesses 106 administrative licenses, further indicating its compliance and operational capabilities within the industry [1]

近5日融资融券数据一览见下表： 证券之星消息，截至2025年8月11日收盘，港通医疗(301515)报收于23.98元，上涨2.39%，换手率 7.93%，成交量5.05万手，成交额1.19亿元。 8月11日的资金流向数据方面，主力资金净流入110.46万元，占总成交额0.93%，游资资金净流出331.85 万元，占总成交额2.79%，散户资金净流入221.39万元，占总成交额1.86%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-08-11 | 23.98 | 2.39% | 110.46万 | 0.93% | -331.85万 | -2.79% | 221.39万 | 1.86% | | 2025-08-08 | | 23.42 0.86% | 429.43万 | 2.51% | 1150.45万 | 6.72% | -1579.88万 | -9.22% | | 2025-0 ...

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Kangtong Medical, indicating a significant decline in revenue and profit for Q1 2025, alongside a high PE ratio compared to industry averages [1][2] - Kangtong Medical's closing stock price is 23.98 yuan, with a rolling PE ratio of 453.01, marking a new low in 338 days, and a total market capitalization of 2.398 billion yuan [1] - The company operates in the medical equipment sector, focusing on the research, design, manufacturing, integration, and operation of medical gas equipment and systems, as well as clean medical equipment [1] Group 2 - The average PE ratio for the medical equipment industry is 56.56, with a median of 39.76, positioning Kangtong Medical at 121st in the industry ranking [1][2] - As of July 31, 2025, Kangtong Medical has 8,816 shareholders, an increase of 100 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The latest financial report for Q1 2025 shows a revenue of 24.2867 million yuan, a year-on-year decrease of 68.09%, and a net profit of 1.579 million yuan, down 85.25%, with a gross margin of 36.15% [1]

经济观察网 医疗器械板块短线拉升，尚荣医疗、赛诺医疗涨停, 爱朋医疗、翔宇医疗涨超10%，伟思医 疗、中红医疗、济高发展、冠昊生物、港通医疗等跟涨。 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Kangtong Medical, which closed at 23.22 yuan with a PE ratio of 438.66, marking a new low in 336 days, and a total market capitalization of 2.322 billion yuan [1][2] - The average PE ratio for the medical device industry is 54.79, with a median of 37.86, positioning Kangtong Medical at 121st in the industry ranking [1][2] - The company experienced a net inflow of 6.5078 million yuan in principal funds on August 7, with a total inflow of 5.2917 million yuan over the past five days [1] Group 2 - Kangtong Medical specializes in the research, design, manufacturing, integration, and operation services of medical gas equipment and clean equipment, with its main products including medical gas equipment and systems [1] - The latest financial report for Q1 2025 shows a revenue of 24.2867 million yuan, a year-on-year decrease of 68.09%, and a net profit of 1.579 million yuan, down 85.25%, with a gross profit margin of 36.15% [1]

Group 1 - The core point of the article highlights that Kangtong Medical (301515) has recently registered a new software copyright for its "Medical Oxygen Machine Control System Software V1.0" project, marking a total of 10 new software copyrights registered this year, which is an increase of 66.67% compared to the same period last year [1] - In terms of research and development, the company invested 24.2452 million yuan in 2024, which represents a year-on-year decrease of 18.83% [1] - Kangtong Medical has made investments in 12 enterprises and participated in 2,965 bidding projects, indicating active engagement in the market [1] Group 2 - The company holds 31 trademark registrations, 309 patent registrations, and 34 copyright registrations, showcasing a strong intellectual property portfolio [1] - Additionally, Kangtong Medical possesses 106 administrative licenses, further indicating its operational capabilities and compliance [1]

从资金流向来看，港通医疗当日主力资金净流入326.51万元，占流通市值的0.22%。近五个交易日主力 资金累计净流出65.32万元，占流通市值的0.04%。 风险提示：投资有风险，入市需谨慎。本文所提及股票仅供信息参考，不构成任何投资建议。 来源：金融界 港通医疗最新股价报22.96元，较前一交易日上涨1.41%。盘中最高触及22.96元，最低下探至22.43元， 成交量为26502手，成交金额达0.60亿元。 该公司主营业务为医疗器械研发、生产和销售，产品涵盖医用气体设备及系统、医用洁净设备及系统等 医疗专业工程领域。港通医疗是四川省专精特新企业，在医疗专业工程领域具有一定市场地位。 根据公司公告，截至2025年7月31日，港通医疗已累计回购公司股份285.88万股，占公司总股本的 2.86%。此次回购通过集中竞价交易方式进行。 ...

Company Overview - The company, Sichuan Portong Medical Equipment Group Co., Ltd., specializes in the research, design, manufacturing, integration, and operation services of medical gas equipment and systems, as well as medical clean equipment and systems [1] - The main products include medical gas equipment and systems, medical clean equipment and systems, medical devices, and other sales and operation services [1] - The company has received multiple accolades, including "National Specialized and Innovative Small Giant Enterprise" and "National High-tech Enterprise" [1] Financial Performance - As of the first quarter of 2025, the company reported a revenue of 24.29 million yuan, representing a year-on-year decrease of 68.09% [1] - The net profit for the same period was 1.58 million yuan, down 85.25% year-on-year, with a sales gross margin of 36.15% [1] Market Position - The company's stock closed at 22.96 yuan, with a rolling price-to-earnings (PE) ratio of 433.75, marking a new low in 334 days [1] - The average PE ratio for the medical device industry is 54.24, with a median of 37.92, placing the company at 121st in industry rankings [1][2] - Only one institution holds shares in the company, with a total holding of 210 shares valued at 0.00 billion yuan [1]